Alexion Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 19 U.S.-traded ETFs. ALXN has around 5.9M shares in the U.S. ETF market. The largest ETF holder of ALXN is the Vanguard S&P 500 ETF (VOO), with approximately 1.41M shares. Investors may also find of interest that the ETF with the largest allocation to ALXN stock is Fidelity Blue Chip Value ETF (FBCV), with a portfolio weight of 2.13%. On average, U.S. ETFs allocate 0.28% of ALXN to their portfolios.
Additionally, ALXN is a favorite stock for Vanilla and Value ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALXN as a holding is the Vanguard Mid-Cap Value ETF (VOE), with a return of 43.12%.